RE:RE:RE:RE:Quentin30 is a pathological prevaricator.Excellent...
Will this be a similar to the seamless Phase II ---> Phase III that the Brad Thomson spoke about at the Richmond Club presentation in October 2016?
If I recall, ONCY had filed for a Phase II study of Pela in combination with FOLFOX-6 and Avastin in female patients with colorectal cancer, metatstatic to the liver.
This is the trial where he announced they would be 'hopefully' filing the Phase III study after the first patient had been treated, in Dec of 2016..
Is this going to be a similar set up... thanks for helping with your clear explanations. You rock.